Taming the chronic kidney disease epidemic: A global view of surveillance efforts

Kidney International

Volumn 86, Issue 2, 2014, Pages 246-250

  Radhakrishnan, Jai ^a   Remuzzi, Giuseppe ^b   Saran, Rajiv ^c   Williams, Desmond E ^d   Rios Burrows, Nilka ^d   Powe, Neil ^e   Brück, Katharina ^f   Wanner, Christoph ^g   Stel, Vianda S ^f   Venuthurupalli, Sree K ^h,i   Hoy, Wendy E ⁱ   Healy, Helen G ^j   Salisbury, Anne ⁱ   Fassett, Robert G ^i,j   O'Donoghue, Donal ^k   Roderick, Paul ^l   Matsuo, Seiichi ^m   Hishida, Akira ⁿ   Imai, Enyu ^o   Iimuro, Satoshi ^p  

^a NewYork Presbyterian Hospital   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^h TOOWOOMBA HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^k UNIVERSITY OF MANCHESTER   (United Kingdom)

^l UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^m NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ Yaizu City Hospital   (Japan)

^o Nakayamadera Imai Clinic   (Japan)

^p UNIVERSITY OF TOKYO HOSPITAL   (Japan)

more..

Author keywords

chronic kidney disease; epidemiology; surveillance

Indexed keywords

AUSTRALIA; AWARENESS; CHRONIC KIDNEY DISEASE; COMORBIDITY; DEATH; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; EPIDEMIC; EUROPE; FUNDING; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH IMPACT ASSESSMENT; HIGH RISK POPULATION; HUMAN; INCIDENCE; JAPAN; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; REVIEW; RISK FACTOR; UNITED KINGDOM; UNITED STATES;

EID: 84905438186     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.190     Document Type: Article

References (29)

1. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. White SL, Chadban SJ, Jan S et al. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 2008; 86: 229-237.
3. Couser WG, Remuzzi G, Mendis S et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80: 1258-1270.
4. Jha V, Garcia-Garcia G, Iseki K et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272.
5. Feehally J. Health burden of kidney disease recognized by UN. Nat Rev Nephrol 2012; 8: 12-13.
6. United States Congress Senate Committee on Appropriations Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies: Departments of Labor, Health and Human Services, Education, and related agencies appropriations for fiscal year 2006: hearings before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Ninth Congress, first session, on H.R. 3010, an act making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies, for the fiscal year ending September 30, 2006, and for other purposes. Government Printing Office: Washington, DC.
7. Saran R, Hedgeman E, Plantinga L et al. CKD Surveillance Team. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol 2010; 5: 152-161PMID: 19965534.
8. Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System - United States. U.S. Department of Health and Human Services. Available at http://www.cdc.gov/ckd/surveillance. (accessed 30 January 2014).
9. U.S. Department of Health and Human Services. Healthy people 2020: chronic kidney disease. Available at http://www.healthypeople.gov/2020 (accessed 30 January 2014).
10. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117.
11. McCullough K. Measuring the population burden of chronic kidney disease: a systematic literature review of estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27: 1812-1821.
12. Kidney Disease: improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 3: 1-150.
13. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14: S131-S138.
14. http://www.anzdata.org.au/anzdata/AnzdataReport/34thReport/ 2011c01-stockflow-v1.2.pdf (accessed on 28 February 2013).
15. Boudville N, Kemp A, Moody H et al. Factors associated with the progression of chronic kidney disease in nephrology practices in Australia. Nephron Clin Prac 2012; 121: 36-41.
16. Venuthurupalli SK, Hoy EW, Healy GH et al. CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia. Nephrol Dial Transplant 2012; 27: iii139-iii145.
17. http://www.abs.gov.au/ausstats/absnsf/Products/ 3235. 0B2010BMain+FeaturesBQueensland?OpenDocument (accessed on 08 May 2013).
18. Renal Services Framework. National Service Framework for Renal Services Part Two: Chronic Kidney Disease, Acute Renal Failure and End of Life Care. Department of Health: London 2005.
19. Quality Outcomes Framework at http://qof.hscic.gov.uk.
20. National Institute for Clinical Excellence. Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care (CG73). NICE: London, 2008.
21. Roderick P, Roth M, Mindell J. Chronic Kidney Disease, Chapter 8 in Health Survey for England 2010. Natcen: London, 2011.
22. Karinaratne K, Stevens P, Irving J et al. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. Neph Dial Transplant 2013; 28: 2107-2116.
23. NHS Kidney Care. Atlas of Variation in Healthcare for People with Kidney Disease. NHS Kidney Care: London, 2012.
24. UK Renal Registry. Reports at www.renalreg.com/Reports/reports.html.
25. Imai E, Matsuo S, Makino H et al. CKD-JAC Study Group. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 2008; 31: 1101-1107.
26. Imai E, Matsuo S, Makino H et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol 2010; 14: 558-570.
27. Akizawa T, Makino H, Matsuo S et al. Chronic Kidney Disease Japan Cohort Study Group. Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol 2011; 15: 248-257.
28. Iimuro S, Imai E, Watanabe T et al. Chronic Kidney Disease Japan Cohort Study Group. Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol 2013; 8: 721-730.
29. Nitta K, Iimuro S, Imai E et al. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol 2013; 17: 730-742.